Status:
COMPLETED
Defects in Opsonophagocytosis in Premature Infants
Lead Sponsor:
University Hospital, Geneva
Collaborating Sponsors:
Gertrude Von Meissner Foundation
European Society of Intensive Care Medicine
Conditions:
Prematurity
Neonatal Sepsis
Eligibility:
All Genders
Brief Summary
The purpose of the study is to characterize innate immune function of premature infants, and identify defects that may be responsible for the development of bacterial sepsis.
Detailed Description
Sepsis is an important problem in preterm infants and carries a significant morbidity and mortality. It is estimated that 20% of premature infants surviving beyond the first three days of life will ha...
Eligibility Criteria
Inclusion
- Premature or term delivery
Exclusion
- none
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00866567
Start Date
October 1 2008
End Date
September 1 2009
Last Update
February 3 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of Geneva
Geneva, Geneva 14, Switzerland, 1211